SBI Leasing Services Co.,Ltd. Logo

SBI Leasing Services Co.,Ltd.

Structures Japanese Operating Leases for aircraft & ships for corporate investors.

5834 | T

Overview

Corporate Details

ISIN(s):
JP3163490000
LEI:
Country:
Japan
Address:
港区六本木一丁目6番1号 泉ガーデンタワー14階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

SBI Leasing Services Co., Ltd., established in 2017, is a financial services firm specializing in structuring and providing Japanese Operating Lease (JOL) products for investments in real assets. The company purchases high-value assets, primarily commercial aircraft and ships, and leases them to global airlines and shipping companies. It creates investment funds based on these leases for corporate investors. Key products include the standard JOL and the JOLCO (Japanese Operating Lease with Call Option), which offer investors benefits such as distributed lease income, potential capital gains, and significant tax advantages like profit equalization and deferral.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-13 03:33
Registration Form
確認書
Japanese 8.2 KB
2025-11-13 03:30
Interim Report
半期報告書-第9期(2025/04/01-2026/03/31)
Japanese 167.4 KB
2025-10-31 08:00
Registration Form
訂正発行登録書
Japanese 8.8 KB
2025-10-28 05:51
Registration Form
訂正発行登録書
Japanese 8.8 KB
2025-06-30 08:36
Registration Form
訂正発行登録書
Japanese 8.8 KB
2025-06-30 08:24
Post-Annual General Meeting Information
臨時報告書
Japanese 24.0 KB
2025-06-24 03:34
Regulatory News Service
内部統制報告書-第8期(2024/04/01-2025/03/31)
Japanese 26.3 KB
2025-06-24 03:32
Regulatory News Service
確認書
Japanese 8.1 KB
2025-06-24 03:30
Annual Report
有価証券報告書-第8期(2024/04/01-2025/03/31)
Japanese 1.9 MB
2025-02-20 02:30
Registration Form
発行登録追補書類(株券、社債券等)
Japanese 54.8 KB
2024-12-02 07:30
Registration Form
発行登録書(株券、社債券等)
Japanese 28.6 KB
2024-11-13 07:32
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-11-13 07:30
Interim Report
半期報告書-第8期(2024/04/01-2025/03/31)
Japanese 180.2 KB
2024-10-04 08:40
Share Issue/Capital Change
訂正臨時報告書
Japanese 29.4 KB
2024-08-30 08:55
Share Issue/Capital Change
臨時報告書
Japanese 28.1 KB

Automate Your Workflow. Get a real-time feed of all SBI Leasing Services Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SBI Leasing Services Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SBI Leasing Services Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel
NRGN
Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060

Talk to a Data Expert

Have a question? We'll get back to you promptly.